StageZero Life Sciences Market Cap

StageZero Life Sciences has a market cap or net worth of $3.64 million as of June 26, 2025. Its market cap has decreased by -29.16% in one year.

Market Cap

3.64M

Enterprise Value

4.97M

Revenue

2.88M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.02

Market Cap Chart

Since January 2, 2001, StageZero Life Sciences's market cap has decreased from 5.07M to 3.64M, a decrease of -28.27%. That is a compound annual growth rate of -1.42%.

Market Cap History

Date	Market Cap	% Change
Apr 8, 2024	3.64M	-13.65%
Dec 28, 2023	4.21M	-6.41%
Dec 30, 2022	4.50M	-78.12%
Dec 31, 2021	20.57M	-42.45%
Dec 31, 2020	35.74M	312.71%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	827.70M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	420.90M
CytoDyn	404.64M
Glass House Brands	389.15M

Market Cap Rankings